CD4 and neoplasm: Overall, the results showed that as treatment continued, the effector memory subset of CD4+ T cells was increased by adding SKI-G-801 in both the TC1 and C3PQ tumor models compared to treatment-naive tumors (*p<0.05, ***p<0.001) (Figures 3A, B).